Bio-Tech’s HR needed a firm understanding of its workforce impact on business results and ways to support new, rigorous organizational design activities, with a focus on increasing workforce productivity and controlling contingent costs.
Bio-Tech engaged HCMI for a high level productivity analysis using advanced workforce productivity metrics from HCMI’s Human Capital Financial Statements (HCFS) as well as headcount, high level talent, and workforce cost data.
Bio-Tech has 16,500 employees and 16,000 contingent workers:
How is Bio-Tech’s productivity relative to competitors?
Where are opportunities to optimize Bio-Tech’s workforce investment?
Is Bio-Tech effectively managing and controlling human capital costs?
Are there talent risks that could impact Bio-Tech’s business goals in the coming years?